Skip to main content
. 2019 Feb 11;9(2):57. doi: 10.3390/biom9020057

Figure 2.

Figure 2

Attitudes of the Russian physicians surveyed (n = 206) towards key policy issues associated with prescribing biosimilars. (A) Attitude towards interchangeability of biologic medicines; (B) Attitude towards automatic substitution of biologic medicines; (C) Attitude towards winner-takes-all tenders. Data were extracted from questions 7a, 7b, and 7d of the questionnaire (see Survey Questionnaire 1).